Leslie L Muldoon

5PUBLICATIONS
48CO-AUTHORS
Te mātai tahumaero o te Māori (Māori epidemiology)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2023
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes.

Jared Stoller, Cymon N Kersch, Leslie L Muldoon

|May 03, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.

Etan Orgel, Kristin R Knight, Yueh-Yun Chi

|Jul 27, 2022
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.

Kutluay Uluc, Prakash Ambady, Matthew K McIntyre

|Apr 28, 2021
Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.

Scott R Burks, Cymon N Kersch, Jaclyn A Witko

|Jun 13, 2020
Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma.

R F Barajas, D Schwartz, H L McConnell

Pageof 1

Frequent Collaborators

4 joint publications

Edward A Neuwelt

3 joint publications

Prakash Ambady

3 joint publications

Aclan Dogan

3 joint publications

Rongwei Fu